Traditional Chinese medicine slow-releasing medicine for treating cardiovascular disease and its preparation method

A technology of cardiovascular and sustained-release agents, which is applied in the field of traditional Chinese medicine sustained-release agents for the treatment of cardiovascular diseases and its preparation, can solve the problems of large fluctuations in blood drug concentration, low content of active ingredients in traditional Chinese medicine, and inability to show curative effects, etc., to achieve increased Coronary blood flow, long-lasting and safe efficacy, and the effect of reducing the number of medications

Inactive Publication Date: 2005-03-23
DONGLING MEDICINES INST SHENYANG CITY
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the side effects of Chinese patent medicines are small, due to the low content of active ingredients in traditional Chinese medicines, the dosage is relatively large, and some medicines have a short half-life in the human body, so they need to be administered several times a day, which is not only inconvenient to take, but also easy to miss doses
What is

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine slow-releasing medicine for treating cardiovascular disease and its preparation method
  • Traditional Chinese medicine slow-releasing medicine for treating cardiovascular disease and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] The sustained-release agent of the present invention is composed of the following raw and auxiliary materials by weight:

[0049] Total flavonoids of Epimedium: Microcrystalline Cellulose: Sodium Carboxymethyl Starch: Hydroxypropyl Methyl Cellulose: Magnesium Stearate=60:27:9:8:1

[0050] The method of making it into a tablet comprises the following steps:

[0051] a. Take Epimedium herbs, chop them, add water to decoct twice, add 20 times the amount of water for the first time, decoct for 2 hours, add 10 times the amount of water for the second time, decoct for 2 hours, combine and filter the decoction, and concentrate the filtrate To the relative density of 1.10 (80 ℃), add ethanol to the alcohol content of 70%, stand, filter or centrifuge, the filtrate is decompressed to recover ethanol, and concentrated to a clear paste with a relative density of 1.10, add 10 times the amount of 10% sodium carbonate (Na 2 CO 3 ) aqueous solution, stirred, filtered or centrifuged,...

Embodiment 2

[0055] The sustained-release agent of the present invention is composed of the following raw and auxiliary materials by weight:

[0056] Total flavonoids of Epimedium: microcrystalline cellulose: sodium carboxymethyl starch: hydroxypropyl methyl cellulose: magnesium stearate=45:30:8:25:3.

[0057] The method for preparing it into a tablet is the same as that in Example 1.

Embodiment 3

[0059] The sustained-release agent of the present invention is composed of the following raw and auxiliary materials by weight:

[0060] Epimedium total flavonoids: microcrystalline cellulose: sodium carboxymethyl starch: hydroxypropyl methyl cellulose: magnesium stearate = 90:5:1:1:0.1.

[0061] The preparation method is the same as that in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A slow-releasing Chinese medicine for treating coronary heart disease and angia pectoris and lowering blood pressure is prepared from epimedium, microcrystalline cellulose, carboxymethyl starch sodium, hydroxypropyl methyl cellulose and magnesium stearate.

Description

technical field [0001] The present invention relates to a traditional Chinese medicine for treating cardiovascular diseases, in particular to a traditional Chinese medicine slow-release preparation for treating cardiovascular diseases and a preparation method thereof. Background technique [0002] Coronary heart disease and angina pectoris are common clinical diseases, which are roughly equivalent to "chest pain" in Chinese medicine, which refers to a disease characterized by chest tightness, even chest pain, shortness of breath, and inability to lie down for wheezing. TCM syndrome differentiation of chest arthralgia can be divided into "heart-blood stasis syndrome", "phlegm congestion syndrome", "yin-cold stagnation syndrome", "heart-kidney yin deficiency syndrome", "qi and yin deficiency syndrome", and "yang-qi deficiency syndrome". (Refer to the "Clinical Guidelines for New Chinese Medicines"). The chest pain involved in the present invention belongs to the "Yang-qi defi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/22A61P9/10
Inventor 熊英
Owner DONGLING MEDICINES INST SHENYANG CITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap